Back to trial

Eligibility Pre-Screening

Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 50%

1.Have you been diagnosed with adenocarcinoma confirmed by a tissue biopsy (histopathology)?